Latest News

Friday, September 23, 2016 | FDA Approval/Clearance, Psoriasis, Amgen, Psoriasis

FDA Approves Humira Biosimilar

The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases. Amjevita is approved for the following ind…

Read the full story

Friday, September 23, 2016 | Personnel/Company News

Launches, Anniversaries and More: Aesthetic News from Around the Web

RealSelf Rolls Out RealSelf Business Pages RealSelf is launching of RealSelf Business Pages so doctors can showcase the full range of providers at a practice as well as the treatments offered befor…

Read the full story

Friday, September 23, 2016 | Atopic Dermatitis, Research and Publications, Atopic Derm, Atopic Dermatitis

Research Elucidates Skin Phenotype of Pediatric Eczema

Pediatric atopic dermatitis (AD) in infants looks a lot different than adult AD, suggesting the need for alternative, and possibly more aggressive, treatment strategies in children. The study, led …

Read the full story

Thursday, September 22, 2016 | Research and Publications, Pfizer

Alopecia Areata Breakthrough: Two Studies Suggest JAK inhibitors May Spur Hair Regrowth

Taken together, two new studies suggest that JAK inhibitors may play a role in treating alopecia areata. Two JAK inhibitors are already approved by the U.S. FDA, XELJANZ® (tofacitinib citr…

Read the full story

Wednesday, September 21, 2016 | Skin Cancer, Skin of Color, Research and Publications

African-American Organ Transplant Recipients at Risk for Skin Cancer

All organ transplant recipients, regardless of race, should receive routine, total-body screenings for skin cancer, according to researchers from Drexel University College of Medicine in Philadelphia.…

Read the full story

Wednesday, September 21, 2016 | Business of Medicine, Personnel/Company News, Acne, Novan

Novan, Inc. Launches IPO, Lists on NASDAQ

Novan, Inc. (the “Company” or “Novan”) today announced the pricing of the Company’s initial public offering of 4,100,000 shares of common stock at a price to the public o…

Read the full story

Tuesday, September 20, 2016 | Rosacea, Research and Publications, National Rosacea Society

National Rosacea Society Awards Three New Grants

The National Rosacea Society (NRS) is funding three new studies in addition to continuing support for two ongoing studies as part of its research grants program. In this round, Luis Garza, MD, an a…

Read the full story

Monday, September 19, 2016 | Atopic Dermatitis, Skin Care, Research and Publications, PuraCap

Ditch the Itch: EpiCeram Helps Relieve Eczema Symptoms

A new survey from PuraCap Pharmaceutical sheds light on the emotional and physical effects of eczema, a pervasive condition that affects 31.6 million people in the US. According to the survey, a la…

Read the full story

Friday, September 16, 2016 | Lasers & Light Devices, Skin Care, Product Launches and Updates

Venus Concept Unveils Venus Freeze Plus for Non-Invasive Anti-Aging Treatments

Venus Concept's non-invasive anti-aging device, Venus Freeze Plus, is now available in the US. It is indicated for the treatment of moderate-to-severe facial wrinkles and rhytides, leading to the …

Read the full story

Thursday, September 15, 2016 | Personnel/Company News, Psoriasis, National Psoriasis Foundation

Save the Date: Sept 28th Marks First Ever PsA Awareness Day

September 28th marks the first-ever Psoriatic Arthritis (PsA) Awareness Day. Launched by Celgene Corporation and the National Psoriasis Foundation (NPF), PsA Awareness Day is dedicated to education…

Read the full story

Wednesday, September 14, 2016 | Skin Cancer, Research and Publications

Skin Cancer Prevention Barriers Cited in Uninsured, Minority, Immigrant Populations

Lack of knowledge, the belief that dark skin is protective, and the dislike of sun protection are barriers to skin cancer prevention in minority and immigrant populations, according to a new study in …

Read the full story

Wednesday, September 14, 2016 | Acquisitions and Mergers, Atopic Dermatitis, Psoriasis, Allergan

Allergan Bolsters Medical Derm Portfolio with Vitae Acquisition

Allergan plc is acquiring Vitae Pharmaceuticals, Inc., a clinical-stage biotechnology company. The move will serve to bolster Allergan’s medical dermatology pipeline, with the addition of VTP…

Read the full story

Tuesday, September 13, 2016 | Personnel/Company News, Cynosure

Cynosure to Name Stephen J. Webber as New CFO

Cynosure, Inc. announced that Stephen J. Webber will join the company on October 10, 2016 as Executive Vice President. Mr. Webber will then become Chief Financial Officer and Chief Accounting Officer …

Read the full story

Tuesday, September 13, 2016 | Skin Care, Product Launches and Updates

ModiFace Launches AI-Based Live-Video Skin Simulation Technology

ModiFace, a provider of augmented reality technology for the beauty and medical industries, unveiled an artificial intelligence (AI) based video editing technology that can realistically simulate skin…

Read the full story

Monday, September 12, 2016 | Acquisitions and Mergers, Business of Medicine, Healthcare Trends, Research and Publications

Is Bigger Better? Group Practices Become the New Norm

Group physician practices are the new normal, and it seems that dermatologists were ahead of the consolidation curb, according to research in the September 2016 issue of Health Affairs. Researchers…

Read the full story
Load More
 Stock Price  Change 
 AbbVie $64.98  -0.15% 
 Allergan $243.94  0.21% 
 Amgen $174.80  -0.47% 
 Bayer AG $102.62  -0.60% 
 Celgene $109.43  -1.03% 
 Cutera $12.00  -2.04% 
 Cynosure $52.93  -2.29% 
 GlaxoSmithKline $43.42  -0.37% 
 Johnson and Johnson $118.81  -0.54% 
 Lily $81.16  -0.16% 
 Nestle $79.09  -1.88% 
 Novartis $81.48  -0.67% 
 Pfizer $34.26  0.32% 
 Proctor and Gamble $87.76  -1.38% 
 Taro $117.75  0.81% 
 Unilever $46.10  -0.73% 
 Valeant $27.72  3.24%